Predictors of Quality of Life in Patients With Myocardial Infarction Combined With Dyslipidemia
Background: Dyslipidemia is an important risk factor for myocardial infarction (MI). This study aimed to examine the health-related quality of life (HRQoL) and its predictors of patients with MI combined with dyslipidemia in China.Methods: Information on patients' sociological characteristics,...
Saved in:
Main Authors: | Mengran Zhang (Author), Pingyu Chen (Author), Yan Zhang (Author), Xi Su (Author), Jiyan Chen (Author), Biao Xu (Author), Jianhong Tao (Author), Zhen Wang (Author), Hongchao Li (Author), Aixia Ma (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic Burden of Myocardial Infarction Combined With Dyslipidemia
by: Pingyu Chen, et al.
Published: (2021) -
Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC
by: Pingyu Chen, et al.
Published: (2022) -
EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION
by: R. D. Kurbanov, et al.
Published: (2015) -
EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION
by: R. D. Kurbanov, et al.
Published: (2015) -
Drugs influencing on PCSK9 activity: modelling of efficacy in patients who had myocardial infarction with uncontrolled dyslipidemia
by: V. I. Ignatyeva, et al.
Published: (2023)